نتائج البحث - "Nandaki Keshavan"

المساهمون: University of Edinburgh, Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Great Ormond Street Hospital for Children [London] (GOSH), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunobiologie des Cellules dendritiques, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris], University of Manchester [Manchester], Rheumatism and autoimmune diseases (RAISE), Mother and Children University Hospital, YJC acknowledges funding from the European Research Council (GA 309449), fellowship and a state subsidy managed by the National Research Agency (ANR, France) under the 'Investments for the Future' (ANR-10-IAHU-01). SR acknowledges funding from the Great Ormond Street Hospital Children’s Charity, the NIHR Great Ormond Street Hospital Biomedical Research Centre and the Lily Foundation., ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010), European Project: 309449,EC:FP7:ERC,ERC-2012-StG_20111109,T1-IFN(2013), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Vougny, Marie-Christine, Instituts Hospitalo-Universitaires - Institut Hospitalo-Universitaire Imagine - - Imagine2010 - ANR-10-IAHU-0001 - IAHU - VALID, Definition and characterization of type I interferonopathies - T1-IFN - - EC:FP7:ERC2013-03-01 - 2018-02-28 - 309449 - VALID

المصدر: Journal of Medical Genetics
Journal of Medical Genetics, BMJ Publishing Group, 2020, 57 (7), pp.475-478. ⟨10.1136/jmedgenet-2019-106457⟩
Journal of Medical Genetics, 2020, 57 (7), pp.475-478. ⟨10.1136/jmedgenet-2019-106457⟩
Crow, Y, Keshavan, N, Barbet, J P, Bercu, G, Bondet, V, Boussard, C, Dedieu, N, Duffy, D, Hully, M, Giardini, A, Gitiaux, C, Rice, G I, Seabra, L, Bader-Meunier, B & Rahman, S 2019, ' Cardiac valve involvement in ADAR-related type I interferonopathy ', Journal of Medical Genetics . https://doi.org/10.1136/jmedgenet-2019-106457Test

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0268ec54dbea00bdf512a6a06ff3b96cTest
https://hal-pasteur.archives-ouvertes.fr/pasteur-02396619Test

6

Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus

المؤلفون: Robert McFarland, Frans G. M. Russel, Mar O'Callaghan, Mitchell E. Allen, Tom J.J. Schirris, Maaike de Vries, Grainne S. Gorman, Costanza Lamperti, Kristin N. Varhaug, Yi Shiau Ng, Robert D S Pitceathly, Laurence A. Bindoff, David Brown, Shamima Rahman, Michelangelo Mancuso, Nandaki Keshavan, Amel Karaa

المساهمون: Medical Microbiology and Infection Prevention

المصدر: Journal of Inherited Metabolic Disease
Journal of inherited metabolic disease, 43(4), 800-818. Springer Netherlands
Journal of Inherited Metabolic Disease, 43, 800-818
Journal of Inherited Metabolic Disease, 43, 4, pp. 800-818

مصطلحات موضوعية: Drug, safety, medicine.medical_specialty, Consensus, Internationality, Delphi Technique, Drug-Related Side Effects and Adverse Reactions, Mitochondrial disease, media_common.quotation_subject, Patient advocacy, drugs, All institutes and research themes of the Radboud University Medical Center, in vivo studies, Toxicity Tests, Genetics, medicine, Humans, mitochondrial toxicity, in vitro studies, mitochondrial diseases, Adverse effect, Intensive care medicine, Genetics (clinical), computer.programming_language, media_common, business.industry, Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6], Original Articles, medicine.disease, Mitochondria, Mitochondrial toxicity, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Drug class, Pharmaceutical Preparations, Drug Design, Practice Guidelines as Topic, Original Article, business, computer, Delphi